-+ 0.00%
-+ 0.00%
-+ 0.00%

Metagenomi Q3 EPS $(0.55) Beats $(0.60) Estimate, Sales $8.659M Beat $7.400M Estimate

Benzinga·11/11/2025 21:04:25
Listen to the news
Metagenomi (NASDAQ:MGX) reported quarterly losses of $(0.55) per share which beat the analyst consensus estimate of $(0.60) by 7.87 percent. This is a 7.84 percent decrease over losses of $(0.51) per share from the same period last year. The company reported quarterly sales of $8.659 million which beat the analyst consensus estimate of $7.400 million by 17.01 percent. This is a 24.80 percent decrease over sales of $11.514 million the same period last year.